Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer
- PMID: 23378937
- PMCID: PMC3559026
- DOI: 10.4172/2165-7092.1000e128
Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.Cell Oncol (Dordr). 2016 Aug;39(4):379-88. doi: 10.1007/s13402-016-0283-7. Epub 2016 May 30. Cell Oncol (Dordr). 2016. PMID: 27240826
-
Systems biology approaches in identifying the targets of natural compounds for cancer therapy.Curr Drug Discov Technol. 2013 Jun;10(2):139-46. doi: 10.2174/1570163811310020006. Curr Drug Discov Technol. 2013. PMID: 23237676 Review.
-
Systems approaches for identifying disease genes and drug targets.Methods. 2017 Dec 1;131:1-3. doi: 10.1016/j.ymeth.2017.10.002. Epub 2017 Oct 9. Methods. 2017. PMID: 29024721 No abstract available.
-
The pancreatic cancer proteome - recent advances and future promise.Proteomics Clin Appl. 2007 Sep;1(9):1066-79. doi: 10.1002/prca.200700144. Proteomics Clin Appl. 2007. PMID: 21136758
-
Extracting biomarkers of commitment to cancer development: potential role of vibrational spectroscopy in systems biology.Expert Rev Mol Diagn. 2015 May;15(5):693-713. doi: 10.1586/14737159.2015.1028372. Epub 2015 Mar 24. Expert Rev Mol Diagn. 2015. PMID: 25804575 Review.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Prasasya RD, Tian D, Kreeger PK. Analysis of cancer signaling networks by systems biology to develop therapies. Semin Cancer Biol. 2011;21:200–206. - PubMed
-
- Faratian D, Bown JL, Smith VA, Langdon SP, Harrison DJ. Cancer systems biology. Methods Mol Biol. 2010;662:245–263. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources